InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by GOLDSTEIN DOV A MD, Director. Director active across 1 companies, notably NeuBase Therapeutics, Inc.. Aggregated, 2 filings have been published. Total volume traded: €64k. The latest transaction was disclosed on 18 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€31,8978,000 shares@ €3.9871100.0% of flow
Common Stock
SEC:0001104659-21-083253·
Ideal exit: 15 Mar 2022 (T+270)
€31,8978,000 shares@ €3.987150.0% of flow
Common Stock
SEC:0001104659-21-083253:0·
Ideal exit: 15 Mar 2022 (T+270)
2 of 2 declarations
About GOLDSTEIN DOV A MD
Dov A. Goldstein is a Board Member at NeuBase Therapeutics, Inc. He contributes to the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is valuable in guiding the company's initiatives. As a board member, he ensures that NeuBase meets its performance and innovation objectives.
